[Drug interactions of lithium. Review of the literature].
The authors have reviewed the literature regarding interactions of lithium and other drugs. The hypothetical physiopathogenic mechanisms of these interactions are discussed even if in some cases the mechanisms are not understood. The interactions of diuretic and anti-inflammatory drugs with lithium will mainly affect renal function and ionic exchange across cell membranes. Other drugs become toxic when associated to lithium because of the addition of their adverse effects. The beneficial effects of some drugs associations are also discussed.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001581:Benzothiadiazines; D004232:Diuretics / Q000009:adverse effects; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy / Q000009:adverse effects; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D007684:Kidney Tubules / Q000187:drug effects; D007700:Kinetics; D008094:Lithium / Q000009:adverse effects* / Q000378:metabolism / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D010640:Phenothiazines; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects
D000893:Anti-Inflammatory Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D001581:Benzothiadiazines; D004232:Diuretics; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D049993:Sodium Chloride Symporter Inhibitors; D008094:Lithium; D006220:Haloperidol
Les interactions médicamenteuses du lithium. Revue de la littérature.